Literature DB >> 2415411

Cyclic AMP mediates the negative regulation of Y-organ ecdysteroid production.

M P Mattson, E Spaziani.   

Abstract

The putative neuropeptide, molt-inhibiting hormone (MIH), regulates crustacean growth by periodically suppressing the secretion of ecdysteroid molting hormone from peripheral glands (Y-organs). A mediating role for cyclic AMP (cAMP) in MIH action was evaluated with isolated Y-organs of the crab, Cancer antennarius. MIH activity in eyestalk extracts inhibited ecdysteroid secretion but increased cAMP levels dose-dependently in 24-h incubations. The cAMP rise preceded the onset of ecdysteroid suppression. Dibutyryl cAMP, activators of adenylate cyclase (forskolin, choleragen), and an inhibitor of phosphodiesterase (IBMX), but not AMP or cGMP, mimicked the inhibitory action of MIH.

Entities:  

Mesh:

Substances:

Year:  1985        PMID: 2415411     DOI: 10.1016/0303-7207(85)90106-6

Source DB:  PubMed          Journal:  Mol Cell Endocrinol        ISSN: 0303-7207            Impact factor:   4.102


  4 in total

1.  A transaldolase : An enzyme implicated in crab steroidogenesis.

Authors:  F Lachaise; G Sommé; G Carpentier; E Granjeon; S Webster; D Baghdassarian
Journal:  Endocrine       Date:  1996-08       Impact factor: 3.633

2.  Effects of the adenylate cyclase activator forskolin and its inactive derivative 1,9-dideoxyforskolin on insect cytochrome P-450 dependent steroid hydroxylase activity.

Authors:  D P Keogh; M J Mitchell; J R Crooks; S L Smith
Journal:  Experientia       Date:  1992-01-15

3.  Molt-inhibiting hormone stimulates vitellogenesis at advanced ovarian developmental stages in the female blue crab, Callinectes sapidus 2: novel specific binding sites in hepatopancreas and cAMP as a second messenger.

Authors:  Nilli Zmora; Amir Sagi; Yonathan Zohar; J Sook Chung
Journal:  Saline Systems       Date:  2009-07-07

Review 4.  The Crustacean Hyperglycemic Hormone Superfamily: Progress Made in the Past Decade.

Authors:  Hsiang-Yin Chen; Jean-Yves Toullec; Chi-Ying Lee
Journal:  Front Endocrinol (Lausanne)       Date:  2020-10-01       Impact factor: 5.555

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.